The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages

Blood

Volumn 117, Issue 10, 2011, Pages 2944-2952

  Souza, Thiago Moreno L ^a,b   Rodrigues, Diego Q ^a   Passaes, Caroline P B ^a   Barreto de Souza, Victor ^a   Aguiar, Renato S ^b   Temerozo, Jairo R ^a   Morgado, Mariza G ^a   Fontes, Carlos Frederico L ^b   Araujo, Elizabeth G ^c   Bou Habib, Dumith Chequer ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE A; SYNAPTOPHYSIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESERVOIR; RETICULUM CELL; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 79953099736     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-287193     Document Type: Article

References (50)

1. Stevenson M. HIV-1 pathogenesis. Nat Med. 2003;9(7):853-860.
2. Peterlin BM, Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol. 2003;3(2):97-107.
3. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med. 1993;177(5):1511-1516.
4. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science. 1997;276(5320):1857-1861.
5. Wahl SM, Greenwell-Wild T, Peng G, Hale-Donze H, Orenstein JM. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J Infect Dis. 1999;179(suppl 3):S457-S460.
6. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med. 1996;334(19):1222-1230.
7. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother. 2001;12(3):133-150.
8. Alfano M, Crotti A, Vicenzi E, Poli G. New players in cytokine control of HIV infection. Curr HIV/AIDS Rep. 2008;5(1):27-32.
9. Copeland KF. Modulation of HIV-1 transcription by cytokines and chemokines. Mini Rev Med Chem. 2005;5(12):1093-1101.
10. Greenwell-Wild T, Vazquez N, Jin W, Rangel Z, Munson PJ, Wahl SM. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood. 2009;114(9):1864-1874.
11. Stopak KS, Chiu YL, Kropp J, Grant RM, Greene WC. Distinct patterns of cytokine regulation ofAPOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem. 2007;282(6):3539-3546.
12. Davies AM. The role of neurotrophins in the developing nervous system. J Neurobiol. 1994;25(11):1334-1348.
13. Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci. 1991;14(5):165-170.
14. Arévalo JC, Wu SH. Neurotrophin signaling: many exciting surprises! Cell Mol Life Sci. 2006;63(13):1523-1537.
15. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A. 1993;90(23):10984-10988.
16. Otten U, Baumann JB, Girard J. Stimulation of the pituitary- adrenocortical axis by nerve growth factor. Nature. 1979;282(5737):413-414.
17. Weskamp G, Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J Neurochem. 1987;48(6):1779-1786.
18. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987;330(6149):658-659.
19. Steiner P, Pfeilschifter J, Boeckh C, Radeke H, Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells. Am J Physiol. 1991;261(5 Pt 2):F792-798.
20. Hattori A, Tanaka E, Murase K, et al. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J Biol Chem. 1993;268(4):2577-2582.
21. Matsuda H, Kannan Y, Ushio H, et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med. 1991;174(1):7-14.
22. Thorpe LW, Stach RW, Hashim GA, Marchetti D, Perez-Polo JR. Receptors for nerve growth factor on rat spleen mononuclear cells. J Neurosci Res. 1987;17(2):128-134.
23. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A. 1989;86(24):10059-10063.
24. Verani A, Gras G, Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol Immunol. 2005;42(2):195-212.
25. Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci U S A. 1993;90(12):5423-5427.
26. Garaci E, Caroleo MC, Aloe L, et al. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci U S A. 1999;96(24):14013-14018.
27. Lima RG, Van Weyenbergh J, Saraiva EM, Barral-Netto M, Galvao-Castro B, Bou-Habib DC. The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J Infect Dis. 2002;185(11):1561-1566.
28. Aiken C, Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol. 1995;69(8):5048-5056.
29. Sundstrom JB, Ellis JE, Hair GA, et al. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood. 2007;109(12):5293-5300.
30. Tanaka Y, Marusawa H, Seno H, et al. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem Biophys Res Commun. 2006;341(2):314-319.
31. Calcaterra S, Cappiello G, Di Caro A, Garbuglia AR, Benedetto A. Comparative analysis of total and integrated HIV-1 DNAin peripheral CD4 lymphocytes and monocytes after long treatment with HAART. J Infect. 2001;43(4):239-245.
32. Kumar R, Vandegraaff N, Mundy L, Burrell CJ, Li P. Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA. J Virol Methods. 2002;105(2):233-246.
33. Fabbro A, Nistri A. Chronic NGF treatment of rat nociceptive DRG neurons in culture facilitates desensitization and deactivation of GABAA receptor-mediated currents. Br J Pharmacol. 2004;142(3):425-434.
34. Samah B, Porcheray F, Dereuddre-Bosquet N, Gras G. Nerve growth factor stimulation promotes CXCL-12 attraction of monocytes but decreases human immunodeficiency virus replication in attracted population. J Neurovirol. 2009;15(1):71-80.
35. Skaper SD. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets. 2008;7(1):46-62.
36. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951;116(2):321-361.
37. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323(5919):1304- 1307.
38. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog. 2007;3(9):1281-1290.
39. Scott JD, Pawson T. Cell signaling in space and time: where proteins come together and when they're apart. Science. 2009;326(5957):1220-1224.
40. Dijkmans TF, van Hooijdonk LW, Schouten TG, et al. Temporal and functional dynamics of the transcriptome during nerve growth factor-induced differentiation. J Neurochem. 2008;105(6):2388-2403.
41. Ensoli F, Ensoli B, Thiele CJ. HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor. Virology. 1994;200(2):668-676.
42. Recio JA, Aranda A. Activation of the HIV-1 long terminal repeat by nerve growth factor. J Biol Chem. 1997;272(43):26807-26810.
43. Boven LA, Middel J, Portegies P, Verhoef J, Jansen GH, Nottet HS. Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex. J Neuroimmunol. 1999;97(1-2):154-162.
44. Corasaniti MT, Bagetta G, Rotiroti D, Nistico G. The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. Biochem Pharmacol. 1998;56(2):153-156.
45. Ramirez SH, Sanchez JF, Dimitri CA, Gelbard HA, Dewhurst S, Maggirwar SB. Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism. J Neurochem. 2001;78(4):874-889.
46. Nosheny RL, Mocchetti I, Bachis A. Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox Res. 2005;8(1-2):187-198.
47. Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Ann N Y Acad Sci. 2007;1122:144-154.
48. Malim MH. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci. 2009;364(1517):675-687.
49. Kinoshita SM, Taguchi S. NF-IL6 (C/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G. Proc Natl Acad Sci U S A. 2008;105(39):15022-15027.
50. Sterneck E, Johnson PF. CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J Neurochem. 1998;70(6):2424-2433.